MYD88 and metabolic dysfunction-associated steatotic liver disease: Concurrently, this deficiency attracted Cx3cr1+Ccr2+ monocyte-derived macrophages that expressed myeloid differentiation primary response gene 88 (MyD88) to activate the NF-κB pathway, thereby amplifying inflammation and stimulating MASLD progression [32].